IMRESPDX

Ischemia

1) AHA/ACC Guidelines for ACS

2) AHA/ACC Guidelines for Lipids

3) COURAGE Trial - PCI vs. medical tx for stable CAD

4) PROVE-IT - high intensity statin

5) CURE trial - ASA+clopidogrel in NSTEMI

6) CABG review in NEJM 2016 (Alexander)

________________________

Arrhythmias

1) AFFIM Trial - rate vs rhythm AFib

2) RACE-II - intensive vs liberate rate control AFib

3) ROCKET-AF - Rivaroxaban in AF

4) RE-LY - Dabigatran in AF

5) ARISTOTLE - Apixiban in AF

6) SPAF Trial - ASA or warfarin in AF

7) SVT Reviewed Paper NEJM

8) CHADS-VASc vs. CHADS2 paper

9) Syncope NEJM

________________________

Heart Failure

1) AHA/ACC Guidelines for Management of Heart Failure

2) CONSENSUS - ACEi in HFrEF

3) COMET - carvedilol in HFrEF

4) RALES - spironolactone in HFrEF (III-IV)

5) EMPHASIS-HF - eplerenone in HFrEF (II-IV)

6) MADIT-CRT - CRT in HFrEF

7) CHFpEF Review Paper

8) Cardiorenal Syndrome - circulation reviews

________________________

Valvular

1) AS Review article

2) PARTNER Trial -  TAVR for AS

________________________

Recent Data

1) PARADIGM-HF - ARNI (sucubitril)

2) TAVR outcomes data JAMA

3) PRODIGY Trial - DAPT 12 vs 30 mos

4) PCSK9 inhibitor (alirocumab) for hypercholesterolemia